Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether desmopressin administered as a melt tablet is effective in reducing the number of wet nights in children and adolescents who suffer from bedwetting.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ferring Pharmaceuticals
NCT06883851 · Primary Nocturnal Enuresis, Nocturnal Enuresis in Children
NCT07424651 · Meatal Stenosis, Primary Nocturnal Enuresis, and more
NCT07003126 · Primary Nocturnal Enuresis
IWK Health Centre
Halifax, Nova Scotia
The Male Health Centres
Barrie, Ontario
Cambridge Family Medical Centre
Cambridge, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions